Abstract
The involvement of synaptosomal neurotransmitter amino-acids in seizure susceptibility and seizure severity was explored. The amino-acid contents of brain synaptosomes were determined in three sublines of Rb mice differing in their response to an acoustic stimulus: Rb1, clonic-tonic seizure-prone, Rb2, clonic seizure-prone, and Rb3, seizure-resistant. Synaptosomes were prepared from 6 brain areas considered to be involved in seizure activity: olfactory bulbs, amygdala, inferior colliculus, hippocampus, cerebellum, pons-medulla. The steady-state levels of GABA and glycine (Gly), inhibitory amino-acids, of taurine (Tau), an inhibitory neurotransmitter of neuromodulator, of aspartate (Asp) and glutamate (Glu), excitatory amino-acids, as well as of serine (Ser) and glutamine (Gln), two precursors of neurotransmitter amino-acids, were determined by HPLC. Low levels of Tau, GABA, and Ser in hippocampus, Gly in amygdala, Glu in hippocampus, inferior colliculus and pons, Gln and Asp in inferior colliculus appeared to correlate with seizure-susceptibility. GABA and Asp in olfactory bulb, Gln in amygdala, hippocampus and pons, ser in olfactory bulb and pons, appeared to be associated either with seizure-severity or-diversity. A strong involvement of hippocampus (Tau, GABA, Ser, Glu, and Gln) and inferior colliculus (Asp, Glu, Gln) in audiogenic seizure-susceptibility, and of olfactory bulb (GABA, Asp) in seizure-severity and/or-diversity is suggested.
Similar content being viewed by others
References
Van Gelder, N. M., and Courtois, A. 1972. Close correlation between changing content of specific amino-acids in epileptic cortex of cats, and severity of epilepsy. Brain Res. 43:477–484.
Emson, P. C. 1978. Biochemical and metabolic changes in epilepsie, in Taurine and Neurological Disorders (Barbeau A. and Huxtable R. J., eds), pp. 319–338. Raven Press, New York.
Bakay, R., and Harris, A. 1981. Neurotransmitter and biochemical changes in monkey cortical epileptic foci. Brain Res. 206:387–404.
Perry, T. L., and Hansen, S. H. 1981. Amino-acid abnormalities in epileptogenic foci. Neurology 31:872–876.
Jobe, P. C., and Laird, H. E. 1981. Neurotransmitter abnormalities as determinants of seizure susceptibility and intensity in the genetic models of epilepsy. Biochem. Pharmacol. 30:3137–3144.
Bonhaus, D. W., Lippincott, S. E., and Huxtable, R. J. 1984. Subcellular distribution of neuroactive amino-acids in brains of genetically epileptic rats. Epilepsia 25:564–568.
Dailey, J. W., Reigel, C. E., Mishra, P. K. J., and Jobe, P. C. 1989. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res. 3:3–17.
Simler, S., Ciesielski, L., Clement, J., and Mandel, P. 1990. Amino-acid neurotransmitter alterations in three sublines of Rb mice differing by their susceptibility to audiogenic seizures. Neurochem. Res. 15:687–693.
Busnel, R. G., and Lehmann, M. 1960. New pharmacodynamic data relative to the audiogenic crisis in the mouse. J. Physiol. 52:37–38.
Schreiber, R. A., Lehmann, A., Ginsburg, B. E., and Fuller, J. L. 1980. Development of susceptibility to audiogenic seizures in DBA/2 J and Rb mice. Toward a systematic nomenclature to audiogenic seizure levels. Behavior Genetics 10:537–543.
Ciesielski, L., Simler, S., Clement, J., and Mandel, P. 1987. Effect of repeated convulsive seizures on brain 4-aminobutyric acid metabolism in three sublines of mice differing by their response to acoustic stimulations. J. Neurochem. 49:220–226.
Sherwin, A., Robitaille, Y., Quesnay, F., Olivier, A., Villemure, J., Leblanc, R., Feindel, W., Andermann, E., Gotman, J., Anderman, R., Ethier, R., and Kish, S. 1988. Excitatory amino-acids are elevated in human epileptical cerebral cortex. Neurology 38:920–923.
Kontro, P., Marnela, K. M., and Oja, S. 1980. Free amino-acids in the synaptosome and synaptic vesicle fractions of different bovine brain areas. Brain Res. 184:129–141.
Wood, J. D. 1981. Evaluation of a synaptosomal model for monitoring in vivo changes in the GABA and glutamate content of nerve endings (minireview). Int. J. Biochem. 13:543–548.
Wood, J. D., and Kurylo, E. 1984. Amino-acid content of nerve endings (synaptosomes) in different regions of brain: effects of gabaculine and isonicotinic acid hydrazide. J. Neurochem. 42:420–425.
Helgason, C. D., and Wood, J. D. 1989. Changes in the amounts of aminoacids associated with nerve endings (synaptosomes) during synaptosomes. Neurochem. Res. 14:297–300.
Simler, S., Ciesielski, L., Gobaille, S., and Mandel, P. 1990. Alterations in synaptosomal neurotransmitter amino-acids in “Petit-Mal” rats a day time and a night time. Neurochem. Res. 15:1079–1084.
Dailey, J. W., Mishra, P. K., Ko, K. H., Penny, J. E., and Jobe, P. C. 1991. Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Epilepsia. 32:168–173.
Löscher, W., Böhme, G., Müller, F., and Pagliusi, S. 1985. Improved method for isolating synaptosomes from 11 regions of one rat brain: electron microscopic and biochemical characterization and use in the study of drug effects on nerve terminal 4-aminobutyric acid in vivo. J. Neurochem. 45:879–889.
Dodd, P. R., Hardy, J. A., Oakley, A. E., Edwardson, J. A., Perry, E. K., and Delaunoy, J. P. 1981. A rapid method for preparing synaptosomes: comparison with alternative procedures. Brain Res. 226:107–118.
Lamar, C. J. 1970. Mercaptopropionic acid: a convulsant that inhibits glutamate decarboxylase. J. Neurochem. 17:165–170.
Seiler, N., and Knodgen, B. 1985. Determination of amino-acids by separation of their ion pairs with dodecyl sulphate. J. Chromatog. 341:11–21.
Lowry, O. H., Rosenbrough, M. J., Farr, A. L., and Randall, R. J. 1951. Protein measurements with the folin phenol reagent. J. Biol. Chem. 193:265–275.
Taurine as Neurotransmitter and-modulator 1985. Pages 237–357, in Oja, S. S., Ahtee, L., Kontro, P., and Paasonen, M. K. (eds.). Taurine: Biological Actions and Clinical Perspectives, Alan R. Liss Inc., New York.
Benjamine, A. M., and Quastel, J. H. 1972. Locations of amino acids in brain slices from the rat. Tetrodoxin-sensitive release of amino-acids. Biochem. J. 128:631–646.
Wood, J. D., Russell, M. P., Kurylo, E., and Newstead, J. D. 1979. Stability of synaptosomal GABA levels and their use in determining the in vivo effects of drugs: convulsant agents. J. Neurochem. 33:61–68.
Dailey, J. W., and Jobe, P. C. 1986. Indices of noradrenergic function in the central nervous system of seizure-nerve genetically epilepsy-prone rats. Epilepsia 27:665–670.
Guilarte, T. R. 1989. Regional changes in the concentrations of glutamate, glycine, taurine and GABA in the vitamine B-6 deficient developing rat brain, association with neonatal seizures. Neurochem. Res. 14:889–897.
Carter, C. J. 1982. Topographical distribution of possible glutaminergic pathways from the frontal cortex to the striatum and substantia nigra in rats. Neuropharmacol. 21:379–383.
Faingold, C. L., Millan, M. H., Boersma Anderson, C. A., and Meldrum, B. S. 1989. Induction of audiogenic seizures in normal and genetically epilepsy-prone rats following focal microinjection of an excitant amino-acid into reticular formation and audiotory nuclei. Epilepsy Res. 3:199–205.
Author information
Authors and Affiliations
Additional information
Special issue dedicated to Dr. Alan N. Davison.
Rights and permissions
About this article
Cite this article
Simler, S., Ciesielski, L., Clement, J. et al. Involvement of synaptosomal neurotransmitter amino acids in audiogenic seizure-susceptibility and-severity of Rb mice. Neurochem Res 17, 953–959 (1992). https://doi.org/10.1007/BF00993272
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00993272